New Results
Chromomycin A2 potently inhibits glucose-stimulated insulin secretion from pancreatic beta cells
View ORCID ProfileMichael A Kalwat, In Hyun Hwang, Jocelyn Macho, Magdalena G Grzemska, Jonathan Z Yang, Kathleen McGlynn, View ORCID ProfileJohn B MacMillan, View ORCID ProfileMelanie H Cobb
doi: https://doi.org/10.1101/337113
Michael A Kalwat
1Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX.
In Hyun Hwang
2Department of Pharmacy, Woosuk University, South Korea.
Jocelyn Macho
3Department of Chemistry & Biochemistry, UC Santa Cruz, Santa Cruz, CA
Magdalena G Grzemska
1Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX.
Jonathan Z Yang
1Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX.
Kathleen McGlynn
1Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX.
John B MacMillan
3Department of Chemistry & Biochemistry, UC Santa Cruz, Santa Cruz, CA
Melanie H Cobb
1Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX.

Article usage
Posted June 04, 2018.
Chromomycin A2 potently inhibits glucose-stimulated insulin secretion from pancreatic beta cells
Michael A Kalwat, In Hyun Hwang, Jocelyn Macho, Magdalena G Grzemska, Jonathan Z Yang, Kathleen McGlynn, John B MacMillan, Melanie H Cobb
bioRxiv 337113; doi: https://doi.org/10.1101/337113
Subject Area
Subject Areas
- Biochemistry (9140)
- Bioengineering (6784)
- Bioinformatics (24005)
- Biophysics (12131)
- Cancer Biology (9537)
- Cell Biology (13781)
- Clinical Trials (138)
- Developmental Biology (7638)
- Ecology (11704)
- Epidemiology (2066)
- Evolutionary Biology (15513)
- Genetics (10647)
- Genomics (14327)
- Immunology (9484)
- Microbiology (22849)
- Molecular Biology (9095)
- Neuroscience (49003)
- Paleontology (355)
- Pathology (1483)
- Pharmacology and Toxicology (2570)
- Physiology (3848)
- Plant Biology (8331)
- Synthetic Biology (2296)
- Systems Biology (6193)
- Zoology (1301)